mhurhangee/patent-ind-claim-en huggingface dataset:
An electromechanical brake actuator for a rail vehicle, the brake actuator comprising a motor configured to move a brake component by being accelerated and decelerated in order to initiate or stop braking of the rail vehicle and to function as a generator while being decelerated, a power supply connector configured to supply electrical components of the brake actuator with electrical energy from outside of the brake actuator , an internal energy storage device connectable to the motor , and a switching device configured to enable and to disable the power supply from the outside of the brake actuator . a motor configured to move a brake component by being accelerated and decelerated in order to initiate or stop braking of the rail vehicle and to function as a generator while being decelerated, a power supply connector configured to supply electrical components of the brake actuator with electrical energy from outside of the brake actuator , an internal energy storage device connectable to the motor , and a switching device configured to enable and to disable the power supply from the outside of the brake actuator .
A disinfectant composition comprising: from about 0.1 wt.% to about 10 wt.% of a primary antiviral agent, wherein the primary antiviral agent includes a polyprotic acid having a first acid dissociation constant of about 3.0 or less; from about 0.1 wt.% to about 15 wt.% of a secondary antiviral agent; and from about 70 wt.% to about 99.5 wt.% of a solvent system that includes one or more solvents, wherein water constitutes at least 50 wt.% of the solvent system; wherein the composition has a pH of about 4.5 or less, wherein the composition exhibits a reduction in virus infectivity of about 30% or more after being exposed to a non-enveloped virus for 10 minutes; and (i) wherein the polyprotic acid is maleic acid and the secondary antiviral agent is decylamine oxide; aluminum chlorohydrate; zinc chloride; or copper (II) chloride; or (ii) wherein the polyprotic acid is sulfosuccinic acid and the secondary antiviral agent is a metal halide salt; or (iii) wherein the polyprotic acid is phosphoric acid and the secondary antiviral agent is sodium methyl oleoyl taurate, copper (II) chloride, urea, guanidine hydrochloride, or aminoguanidine hydrochloride. from about 0.1 wt.% to about 10 wt.% of a primary antiviral agent, wherein the primary antiviral agent includes a polyprotic acid having a first acid dissociation constant of about 3.0 or less; from about 0.1 wt.% to about 15 wt.% of a secondary antiviral agent; and from about 70 wt.% to about 99.5 wt.% of a solvent system that includes one or more solvents, wherein water constitutes at least 50 wt.% of the solvent system; wherein the composition has a pH of about 4.5 or less, wherein the composition exhibits a reduction in virus infectivity of about 30% or more after being exposed to a non-enveloped virus for 10 minutes; and (i) wherein the polyprotic acid is maleic acid and the secondary antiviral agent is decylamine oxide; aluminum chlorohydrate; zinc chloride; or copper (II) chloride; or (ii) wherein the polyprotic acid is sulfosuccinic acid and the secondary antiviral agent is a metal halide salt; or (iii) wherein the polyprotic acid is phosphoric acid and the secondary antiviral agent is sodium methyl oleoyl taurate, copper (II) chloride, urea, guanidine hydrochloride, or aminoguanidine hydrochloride. (i) wherein the polyprotic acid is maleic acid and the secondary antiviral agent is decylamine oxide; aluminum chlorohydrate; zinc chloride; or copper (II) chloride; or (ii) wherein the polyprotic acid is sulfosuccinic acid and the secondary antiviral agent is a metal halide salt; or (iii) wherein the polyprotic acid is phosphoric acid and the secondary antiviral agent is sodium methyl oleoyl taurate, copper (II) chloride, urea, guanidine hydrochloride, or aminoguanidine hydrochloride.
A carbonate-containing silane compound having the general formula : wherein R 1 and R 4 are each independently a substituted or unsubstituted C 1 -C 10 straight or branched divalent hydrocarbon group, R 2 , R 3 , R 5 , R 6 and R 7 are each independently a substituted or unsubstituted C 1 -C 10 straight or branched alkyl or alkenyl group, R 8 is an unsubstituted C 1 -C 10 monovalent hydrocarbon group, and n is 1 or 2.
A dressing for use in a method for reducing microbial load at a site on the skin of a subject in preparation for a subsequent medical procedure that involves breaching the skin of the subject, the method comprising: up to 7 days prior to when the subsequent medical procedure is to be performed, applying or having the subject apply the dressing over the site on the skin of the subject at which the subsequent medical procedure is to be performed, the dressing comprising a self-adhesive silicone gel sheet comprising at least about 95 wt% silicone and up to about 5 wt% of particulates of an antimicrobial dispersed in the silicone, the dressing applied with the silicone gel sheet contacting the skin of the subject; leaving the dressing in place up until the when the subject is to be prepared for the subsequent medical procedure, to allow the antimicrobial to diffuse onto the site, thereby reducing the microbial load on the skin contacted by the silicone gel sheet to sufficiently disinfect the site on the skin in preparation for the subsequent medical procedure; and removing the dressing. up to 7 days prior to when the subsequent medical procedure is to be performed, applying or having the subject apply the dressing over the site on the skin of the subject at which the subsequent medical procedure is to be performed, the dressing comprising a self-adhesive silicone gel sheet comprising at least about 95 wt% silicone and up to about 5 wt% of particulates of an antimicrobial dispersed in the silicone, the dressing applied with the silicone gel sheet contacting the skin of the subject; leaving the dressing in place up until the when the subject is to be prepared for the subsequent medical procedure, to allow the antimicrobial to diffuse onto the site, thereby reducing the microbial load on the skin contacted by the silicone gel sheet to sufficiently disinfect the site on the skin in preparation for the subsequent medical procedure; and removing the dressing.
A mold for making a prophylactic device , the mold comprising: a first area shaped to form material into at least a portion of a distal tip of a prophylactic device ; a second area continuous with the first area shaped to form the material into at least a portion of a tubular body continuous with the distal tip , the tubular body comprising a textured pattern along the tubular body with lines running in at least three directions forming a plurality of shapes with portions of the lines forming edges of the shapes , the textured pattern forming a reinforcing mesh on or in the tubular body ; and a third area continuous with the second area shaped to form the material into at least a portion of a proximal base continuous with the tubular body; and characterised in that the lines of the textured pattern form edges of a plurality of the shapes and wherein none of the edges are formed by a continuous line running in a single direction across more than one shape. a first area shaped to form material into at least a portion of a distal tip of a prophylactic device ; a second area continuous with the first area shaped to form the material into at least a portion of a tubular body continuous with the distal tip , the tubular body comprising a textured pattern along the tubular body with lines running in at least three directions forming a plurality of shapes with portions of the lines forming edges of the shapes , the textured pattern forming a reinforcing mesh on or in the tubular body ; and a third area continuous with the second area shaped to form the material into at least a portion of a proximal base continuous with the tubular body; and characterised in that the lines of the textured pattern form edges of a plurality of the shapes and
A cyclone separation device, comprising: a swirl chamber for swirling air containing dust along a sidewall therein to separate dust from the air containing dust; and a dust collection chamber communicating with an inside of the swirl chamber , the dust collection chamber configured to be able to be in a collection state for collecting the dust separated by the swirl chamber and a disposal state for disposing of the collected dust, an inner wall surface of the dust collection chamber configured to be in a first state when the dust collection chamber is in the collection state and become in a second state when the dust collection chamber become in the disposal state, characterized in that , when a state of the inner wall surface shifts from the first state to the second state, a contact area between the inner wall surface and the dust stuck on the surface is decreasing. a swirl chamber for swirling air containing dust along a sidewall therein to separate dust from the air containing dust; and a dust collection chamber communicating with an inside of the swirl chamber , the dust collection chamber configured to be able to be in a collection state for collecting the dust separated by the swirl chamber and a disposal state for disposing of the collected dust, an inner wall surface of the dust collection chamber configured to be in a first state when the dust collection chamber is in the collection state and become in a second state when the dust collection chamber become in the disposal state, characterized in that , when a state of the inner wall surface shifts from the first state to the second state, a contact area between the inner wall surface and the dust stuck on the surface is decreasing.
Tire comprising at least one rubber composition based on at least a non-isoprene diene elastomer as predominent elastomer, an inorganic filler as reinforcing filler, a crosslinking system and at least one polysulphide of general formula (I) as coupling agent of the elastomer to the reinforcing inorganic filler in which : - A 1 and A 2 , each represent an associative group comprising at least one nitrogen atom, corresponding to the formula (VII) in which the symbol * represents the direct bonding of the A 1 and A 2 groups to the Q 1 and Q 2 groups respectively, - Q 1 and Q 2 , identical or different, each represent a divalent bonding group, - x is a number greater than or equal to 2. - A 1 and A 2 , each represent an associative group comprising at least one nitrogen atom, corresponding to the formula (VII) in which the symbol * represents the direct bonding of the A 1 and A 2 groups to the Q 1 and Q 2 groups respectively, - Q 1 and Q 2 , identical or different, each represent a divalent bonding group, - x is a number greater than or equal to 2.
An aquarium lighting system comprising: a base layer ; a set of lighting elements mounted on the base layer; a beam shaping element associated with each lighting element, wherein the beam shaping element is for passing first light which is emitted from the lighting element at an angle to the normal below a threshold and for processing second light which is emitted from the lighting element at an angle to the normal above the threshold, the processing resulting in a greater amount of scattering of the second light compared to the passed first light, wherein the beam shaping element comprises a plate having a patterned diffuser , with an opening in the diffuser pattern for passing the first light, or wherein the beam shaping element comprises a patterned light guide having an opening in the light guide for passing the first light, the patterned light guide being arranged to capture the second light into the light guide at a side face of the light guide and subsequently reemit the second light from the light guide by means of a scattering element or surface. a base layer ; a set of lighting elements mounted on the base layer; a beam shaping element associated with each lighting element, wherein the beam shaping element is for passing first light which is emitted from the lighting element at an angle to the normal below a threshold and for processing second light which is emitted from the lighting element at an angle to the normal above the threshold, the processing resulting in a greater amount of scattering of the second light compared to the passed first light, wherein the beam shaping element comprises a plate having a patterned diffuser , with an opening in the diffuser pattern for passing the first light, or wherein the beam shaping element comprises a patterned light guide having an opening in the light guide for passing the first light, the patterned light guide being arranged to capture the second light into the light guide at a side face of the light guide and subsequently reemit the second light from the light guide by means of a scattering element or surface.
A method for manufacturing a fishing bait comprising - forming a basic solution comprising water, gelatine and sugar alcohol at a temperature of at least 70°C, the basic solution having a volume, - boiling the basic solution, - evaporating water under negative pressure in order to adjust the dry matter content of the basic solution, - forming a mouldable composition by adding a cross-linking agent to the volume of the basic solution after water has been evaporated from the basic solution, and - pouring the mouldable composition into at least one mould to form the fishing bait. - forming a basic solution comprising water, gelatine and sugar alcohol at a temperature of at least 70°C, the basic solution having a volume, - boiling the basic solution, - evaporating water under negative pressure in order to adjust the dry matter content of the basic solution, - forming a mouldable composition by adding a cross-linking agent to the volume of the basic solution after water has been evaporated from the basic solution, and - pouring the mouldable composition into at least one mould to form the fishing bait.
An apparatus for controlling the bio-mechanical ventricle-aorta matching of a patient, said apparatus comprising: a balloon , said balloon being inflatable through a catheter introducible in the arterial system of the patient, the apparatus being intended to provide quantities of medical gas at a controlled pressure to said balloon ; a container , that can be loaded with medical gas from a gas source , at a compliance pressure (Pc), and can be set in direct fluid communication with the balloon for the whole treatment of the patient, said apparatus being characterized in that said container consists of a damping container in form of a bag, with the volume of said damping bag being significantly greater than the volume of the balloon , fine adjusting means of said compliance pressure (Pc) being provided to act on said damping bag in such a way that said compliance pressure (Pc) is maintained between the systolic pressure and the diastolic pressure of the patient.
A cooling module for electronic equiment comprising a first air inlet, a second air inlet, and an air discharge vent, the module having two check valves (130.1, 130.2), each mounted in register with a respective inlet and arranged to allow air to pass towards the inside of the module and to oppose a flow of air in the opposite direction, the second air inlet being an external air intake associated with a fan for injecting air into the common module, Characterized in that the first air inlet is connected to a pipe of air under pressure.
A battery pack , comprising: an enclosure ; a plurality of network nodes inside the enclosure, each network node having at least one battery cell and a battery cell controller that generates a unique radio frequency, RF, signature; and a special-purpose computer processor that compares an incoming channel impulse response, CIR, of the unique radio frequency, RF, signal signature corresponding to an incoming packet exchanged between a battery cell controller and a battery management unit inside the enclosure to a plurality of stored valid RF CIR signatures and executes a resemblance metric to accept or reject the incoming packet. an enclosure ; a plurality of network nodes inside the enclosure, each network node having at least one battery cell and a battery cell controller that generates a unique radio frequency, RF, signature; and a special-purpose computer processor that compares an incoming channel impulse response, CIR, of the unique radio frequency, RF, signal signature corresponding to an incoming packet exchanged between a battery cell controller and a battery management unit inside the enclosure to a plurality of stored valid RF CIR signatures and executes a resemblance metric to accept or reject the incoming packet.
A liquid ink, comprising: a pigment dispersion; a polyurethane dispersion; a polytetrafluoroethylene wax emulsion, wherein a particle diameter of a polytetrafluoroethylene wax in the polytetrafluoroethylene wax emulsion is less than 50 nm; a co-solvent; and a balance of water. a pigment dispersion; a polyurethane dispersion; a polytetrafluoroethylene wax emulsion, wherein a particle diameter of a polytetrafluoroethylene wax in the polytetrafluoroethylene wax emulsion is less than 50 nm; a co-solvent; and a balance of water.
A method in a router for Label Switched Path, LSP, traceroute, comprising: receiving an echo request packet containing a label stack and the method being characterized by comprising the steps of: determining from the label stack that forwarding to a downstream router is to be based on a binding segment identifier; identifying a plurality of segments included in a binding segment associated with the binding segment identifier; and transmitting an echo reply packet to a router originating the echo request packet, the echo reply packet containing information indicating a presence of the binding segment identifier in the label stack and indicating a segment identifier associated with each of the plurality of segments. determining from the label stack that forwarding to a downstream router is to be based on a binding segment identifier; identifying a plurality of segments included in a binding segment associated with the binding segment identifier; and transmitting an echo reply packet to a router originating the echo request packet, the echo reply packet containing information indicating a presence of the binding segment identifier in the label stack and indicating a segment identifier associated with each of the plurality of segments.
An apparatus , comprising: - an input to receive an aerosol sample flow (FG1), - a modifier unit to provide a modified sample flow (MG1) by removing particles (P1) of the aerosol sample flow (FG1), and - a sensor unit (SEN1) to detect molecules (VOC1) of the gas phase of the modified sample flow (MG1), wherein the modifier unit is arranged to generate a corona discharge (DSR1) with a corona electrode (ELEC1), to form charged particles (P2) by charging particles (P1) of the aerosol sample flow (FG1) with the corona discharge (DSR1), to generate chemically active species (O3, NOX) with the corona discharge (DSR1), and to provide the modified sample flow (MG1) by mixing the chemically active species (O 3 , NOx) with the aerosol sample flow (FG1) and by removing the charged particles (P2) with an electric field (EF1), the particle removal efficiency (EFF(d)) of the modifier unit has a cutoff size (D CUT ) to prevent propagation of particles larger than the cutoff size (d CUT ) to the sensor unit (SEN1), wherein the modifier unit comprises a counter-electrode (ELEC2) for generating the electric field (EF1), the modifier unit is arranged to form the modified sample flow (MG1) and a second partial flow (MG2) from the aerosol sample flow (FG1) by deflecting the charged particles (P2) with the electric field (EF1) from the modified sample flow (MG1) to the second partial flow (MG2), and wherein the modifier unit comprises a flow divider to separate the modified sample flow (MG1) from the second partial flow (MG2) and also from the deflected particles (P2) carried in the second partial flow (MG2), characterized in that the sensor unit (SEN1) is arranged to measure a spectral profile (PRF) by detecting molecules (VOC1) of the gas phase of the modified sample flow (MG1), wherein the spectral profile (PRF) is a mobility spectrum or a mass spectrometer spectrum, wherein the modifier unit is arranged to generate the chemically active species (O 3 , NO x ) by guiding at least a part of the aerosol sample flow (FG1) via the corona discharge (DSR1). - an input to receive an aerosol sample flow (FG1), - a modifier unit to provide a modified sample flow (MG1) by removing particles (P1) of the aerosol sample flow (FG1), and - a sensor unit (SEN1) to detect molecules (VOC1) of the gas phase of the modified sample flow (MG1),
A resin suitable for use in the fabrication of a light emitting device, the resin comprising a plurality of nanoparticles dispersed in an encapsulation medium, wherein the nanoparticles are photoluminescent conjugated polymer nanoparticles formed from a π-conjugated cross-linked polymer, the π-conjugated cross-linked polymer comprising a) 80-99.9 mol.% of π-conjugated monomers, and b) 0.1-20 mol.% of a cross-linker having the formula I shown below: wherein Z 1 and Z 2 are monomeric moieties, and Y is absent, a bond, or a linking group; and wherein: (i) the nanoparticles comprise 3-10 mol% of the cross-linker; (ii) the loading of nanoparticles within the resin is 0.005 to 5 wt.%; and (iii) the encapsulation medium is a transparent polymeric encapsulation medium. a) 80-99.9 mol.% of π-conjugated monomers, and b) 0.1-20 mol.% of a cross-linker having the formula I shown below: wherein Z 1 and Z 2 are monomeric moieties, and Y is absent, a bond, or a linking group; and wherein: (i) the nanoparticles comprise 3-10 mol% of the cross-linker; (ii) the loading of nanoparticles within the resin is 0.005 to 5 wt.%; and (iii) the encapsulation medium is a transparent polymeric encapsulation medium. Z 1 and Z 2 are monomeric moieties, and Y is absent, a bond, or a linking group; and wherein: (i) the nanoparticles comprise 3-10 mol% of the cross-linker; (ii) the loading of nanoparticles within the resin is 0.005 to 5 wt.%; and (iii) the encapsulation medium is a transparent polymeric encapsulation medium. (i) the nanoparticles comprise 3-10 mol% of the cross-linker; (ii) the loading of nanoparticles within the resin is 0.005 to 5 wt.%; and (iii) the encapsulation medium is a transparent polymeric encapsulation medium.
A peptide comprising an amino acid sequence as set forth in SEQ ID NO: 1, wherein: (i) X at position 1 is arginine or no amino acid; (ii) X at position 2 is glycine or no amino acid; (iii) X at position 5 is histidine or threonine, preferably histidine; (iv) X at position 11 is alanine, glycine or valine, preferably alanine; and (v) X at position 14 is arginine or lysine, preferably arginine, wherein when X at position 1 is no amino acid, X at position 2 is no amino acid, and wherein said peptide is capable of spontaneously forming an isopeptide bond with a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO: 2, wherein said isopeptide bond forms between the aspartic acid residue at position 10 of SEQ ID NO: 1 and the lysine residue at position 34 of SEQ ID NO: 2. (i) X at position 1 is arginine or no amino acid; (ii) X at position 2 is glycine or no amino acid; (iii) X at position 5 is histidine or threonine, preferably histidine; (iv) X at position 11 is alanine, glycine or valine, preferably alanine; and (v) X at position 14 is arginine or lysine, preferably arginine,